The thread of life Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (1232)	1/6/2007 10:23:39 PM
From: Mike McFarland	Read Replies (1) of 1336

My guess is the money that normally goes into affx sloshed into ilmn, and then some of that sloshed into sqnm. But I'd like to think the pump is primed and suddenly genotyping and pharmacogenomics is going to be the rocket fuel for the sector this year. We will see about that... But there is obviously something going on... affymetrix.com The AmpliChip CYP 450 test is Roche's first test to use microarray technology for comprehensive analysis of two genes that can influence drug efficacy and adverse drug reactions. Even something as basic as this is surely not showing up in doctor's offices. The effect on clinical trial design rings true and seems important.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next